Lacosamide has protective disease modifying properties in experimental vincristine neuropathy

Neuropharmacology

Volumn 61, Issue 4, 2011, Pages 600-607

  Geis, Christian ^a   Beyreuther, Bettina K ^b,c   Stöhr, Thomas ^b,d   Sommer, Claudia ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Schwarz Pharma AG   (Germany)

^c Beyreuther Consulting   (Germany)

^d A2M Pharma GmbH   (Germany)

Author keywords

Chemotherapy induced painful neuropathy; Cold allodynia; Disease modifying; Lacosamide; Vincristine

Indexed keywords

HARKOSERIDE; VINCRISTINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENCY; DRUG TOLERABILITY; LATENT PERIOD; MALE; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAPID RELEASE FORMULATION; RAT; SINGLE DRUG DOSE; SUSTAINED RELEASE FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION;

ACETAMIDES; ANIMALS; MALE; NEURALGIA; NEUROPROTECTIVE AGENTS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; VINCRISTINE;

EID: 79959970418     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.05.001     Document Type: Article

References (35)

1. A.A. Argyriou, E. Chroni, A. Koutras, G. Iconomou, S. Papapetropoulos, P. Polychronopoulos, and H.P. Kalofonos Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation J. Pain Symptom Manage. 32 2006 237 244 (Pubitemid 44308452)
2. L.A. Bee, and A.H. Dickenson Effects of lacosamide, a novel sodium channel modulator, on dorsal horn neuronal responses in a rat model of neuropathy Neuropharmacology 57 2009 472 479
3. B.K. Beyreuther, N. Callizot, M.D. Brot, R. Feldman, S.C. Bain, and T. Stohr Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain Eur. J. Pharmacol. 565 2007 98 104 (Pubitemid 46782774)
4. B.K. Beyreuther, J. Freitag, C. Heers, N. Krebsfanger, U. Scharfenecker, and T. Stohr Lacosamide: a review of preclinical properties CNS Drug Rev. 13 2007 21 42 (Pubitemid 46697839)
5. B.K. Beyreuther, C. Geis, T. Stohr, and C. Sommer Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF Neuropharmacology 52 2007 1312 1317 (Pubitemid 46527705)
6. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh Quantitative assessment of tactile allodynia in the rat paw J. Neurosci. Methods 53 1994 55 63 (Pubitemid 24238751)
7. Y. Choi, Y.W. Yoon, H.S. Na, S.H. Kim, and J.M. Chung Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain Pain 59 1994 369 376
8. P. Doty, G.D. Rudd, T. Stoehr, and D. Thomas Lacosamide Neurotherapeutics 4 2007 145 148 (Pubitemid 46107317)
9. P.M. Dougherty, J.P. Cata, A.W. Burton, K. Vu, and H.R. Weng Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain J. Pain Symptom Manage. 33 2007 166 179 (Pubitemid 46186866)
10. J.P. Durand, C. Brezault, and F. Goldwasser Protection against oxaliplatin acute neurosensory toxicity by venlafaxine Anticancer Drugs 14 2003 423 425 (Pubitemid 36951792)
11. A.C. Errington, T. Stohr, C. Heers, and G. Lees The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels Mol. Pharmacol. 73 2008 157 169 (Pubitemid 350294207)
12. J.E. Hammack, J.C. Michalak, C.L. Loprinzi, J.A. Sloan, P.J. Novotny, G.S. Soori, M.T. Tirona, K.M. Rowland Jr., P.J. Stella, and J.A. Johnson Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Pain 98 2002 195 203 (Pubitemid 34722482)
13. H.S. Hochster, A. Grothey, and B.H. Childs Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity J. Clin. Oncol. 25 2007 4028 4029 (Pubitemid 47477294)
14. F.M. Ja'afer, F.B. Hamdan, and F.H. Mohammed Vincristine-induced neuropathy in rat: electrophysiological and histological study Exp. Brain Res. 173 2006 334 345 (Pubitemid 44264898)
15. T.J. Kaley, and L.M. Deangelis Therapy of chemotherapy-induced peripheral neuropathy Br. J. Haematol. 145 2009 3 14
16. A.L. Kautio, M. Haanpaa, T. Saarto, and E. Kalso Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms J. Pain Symptom Manage. 35 2008 31 39 (Pubitemid 350299098)
17. C. Kilkenny, W.J. Browne, I.C. Cuthill, M. Emerson, and D.G. Altman Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol 8 2010 e1000412
18. A. Kroner, N. Schwab, C.W. Ip, C. Sommer, C. Wessig, H. Wiendl, and R. Martini The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy Neurobiol. Dis. 33 2009 96 103
19. M.R. Macleod, M. Fisher, V. O'Collins, E.S. Sena, U. Dirnagl, P.M. Bath, A. Buchan, H.B. van der Worp, R. Traystman, K. Minematsu, G.A. Donnan, and D.W. Howells Good laboratory practice: preventing introduction of bias at the bench Stroke 40 2009 e50 e52
20. N. Nozaki-Taguchi, S.R. Chaplan, E.S. Higuera, R.C. Ajakwe, and T.L. Yaksh Vincristine-induced allodynia in the rat Pain 93 2001 69 76 (Pubitemid 32530844)
21. T.J. Postma, B.A. Benard, P.C. Huijgens, G.J. Ossenkoppele, and J.J. Heimans Long-term effects of vincristine on the peripheral nervous system J. Neurooncol. 15 1993 23 27 (Pubitemid 23049695)
22. R.D. Rao, J.C. Michalak, J.A. Sloan, C.L. Loprinzi, G.S. Soori, D.A. Nikcevich, D.O. Warner, P. Novotny, L.A. Kutteh, and G.Y. Wong Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3) Cancer 110 2007 2110 2118 (Pubitemid 350036873)
23. R.D. Rao, P.J. Flynn, J.A. Sloan, G.Y. Wong, P. Novotny, D.B. Johnson, H.M. Gross, S.I. Renno, M. Nashawaty, and C.L. Loprinzi Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3 Cancer 112 2008 2802 2808 (Pubitemid 351969227)
24. R.L. Rauck, A. Shaibani, V. Biton, J. Simpson, and B. Koch Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study Clin. J. Pain 23 2007 150 158 (Pubitemid 46150939)
25. A.E. Runker, I. Kobsar, T. Fink, G. Loers, T. Tilling, P. Putthoff, C. Wessig, R. Martini, and M. Schachner Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder J. Cell Biol. 165 2004 565 573 (Pubitemid 38679621)
26. D.M. Savarese, G. Savy, L. Vahdat, P.E. Wischmeyer, and B. Corey Prevention of chemotherapy and radiation toxicity with glutamine Cancer Treat. Rev. 29 2003 501 513 (Pubitemid 37428322)
27. A. Shaibani, S. Fares, J.L. Selam, A. Arslanian, J. Simpson, D. Sen, and S. Bongardt Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial J. Pain 10 2009 818 828
28. P.L. Sheets, C. Heers, T. Stoehr, and T.R. Cummins Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine J. Pharmacol. Exp. Ther. 326 2008 89 99 (Pubitemid 351872141)
29. K.D. Tanner, J.D. Levine, and K.S. Topp Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat J. Comp. Neurol. 395 1998 481 492 (Pubitemid 28226093)
30. C.C. Verstappen, S. Koeppen, J.J. Heimans, P.C. Huijgens, M.E. Scheulen, D. Strumberg, B. Kiburg, and T.J. Postma Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening Neurology 64 2005 1076 1077 (Pubitemid 40388469)
31. Y. Wang, J.M. Brittain, B.W. Jarecki, K.D. Park, S.M. Wilson, B. Wang, R. Hale, S.O. Meroueh, T.R. Cummins, and R. Khanna In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein 2 (CRMP-2) identifies a pocket important in modulating sodium channel slow inactivation J. Biol. Chem. 2010
32. H.R. Weng, J.V. Cordella, and P.M. Dougherty Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia Pain 103 2003 131 138 (Pubitemid 36579093)
33. S. Wolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies Eur. J. Cancer 44 2008 1507 1515
34. J.P. Wymer, J. Simpson, D. Sen, and S. Bongardt Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens Clin. J. Pain 25 2009 376 385
35. W.H. Xiao, and G.J. Bennett Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine Pain 135 2008 262 270 (Pubitemid 351330186)